Senior commercial and marketing leader with 20+ years of experience leading product strategy, lifecycle management, and commercialization for dermatology, pediatrics, and episodic therapies. Proven record of owning brand performance, positioning, launch execution, and payer value development in compliance-sensitive markets. Background spans early-stage startups through global pharmaceutical portfolios, with a consistent focus on translating science into clear value propositions that drive adoption, simplify physician decision-making, and improve patient experience. Recognized for operating effectively in lean, execution-first environments, partnering closely with executive leadership, medical, regulatory, sales, and external agencies to deliver commercial impact.
Work History
Independent Consultant
JLB Healthcare Consulting, LLC
Scottsdale, USA
2017 - Current
Consult with early-stage and growth-stage companies on market entry strategies, customer adoption initiatives, portfolio prioritization, and tactical execution.
Acted as interim Head of Marketing for various early-stage companies, converting three consulting roles into full-time executive leadership positions.
Collaborated with clients such as Palette Life Sciences, DOMPÉ, Galderma, AbbVie/Allergan, Rion Aesthetics, and multiple healthcare communications agencies.
Vice President, Strategic Marketing
Rapalogix Health
Scottsdale, USA
2024 - 2025
Third founding hire for a longevity-science aesthetic startup developing RLX-201, a proprietary selective mTORC1-modulating molecule powering the company's Pro-Longevity skincare platform. Accountable for end-to-end commercialization strategy and brand performance, including positioning, launch planning, pricing, claims development, physician education, and cross-functional execution.
Partnered directly with the CEO, R&D, clinical, operations, and investor stakeholders to build the commercial foundation of the company, aligning scientific innovation with real-world adoption dynamics.
Led the development of the company's first hero product from concept through launch readiness, including the target product profile, competitive differentiation, packaging, and go-to-market sequencing.
Created and launched a new aesthetics category centered on cellular aging biology, developing messaging frameworks that balanced scientific credibility with physician clarity.
Owned brand budgets, forecasts, and resource allocation.
Partnered with Medical Affairs to author scientific narratives, white papers, advisory board materials, and physician-facing education modules to support category creation and long-term lifecycle growth.
Built an integrated content ecosystem spanning brand storytelling, scientific visualization, digital assets, social strategy, and leadership visibility.
Chief Marketing Officer
Rion Aesthetics
Santa Barbara, USA
2021 - 2023
Early-stage regenerative aesthetics company with exosome-based skincare products and a developing injectable biologics pipeline.Architected the commercial strategy for a high-science dermatology brand, transitioning from retail distribution to a physician-dispensed model.
Successfully launched three products in the first year, exceeding revenue forecasts by 42%, through disciplined positioning, pricing strategy, and physician engagement.
Led P&L-driven initiatives, including the introduction of first-to-market refillable packaging, reducing COGS while improving sustainability and profitability.
Rebuilt the digital and e-commerce experience to support both consumer demand and physician account acquisition, turning social platforms into lead-generating engines.
Collaborated with clinical and manufacturing teams to accelerate the development and launch of additional SKUs, strengthening the brand's position in regenerative dermatology.
Client Service Lead
Omnicom Health Group
San Francisco, California
2008 - 2016
Senior executive leader managing complex pharmaceutical and dermatology portfolios across ophthalmology, infectious disease, and aesthetics. Led integrated brand strategy and launch execution for acute ophthalmic and otic therapies, including Vigamox, Moxeza, and Ciprodex, in highly competitive, genericized pediatric markets.
Supported lifecycle strategies defend premium branded positioning by reframing value around compliance, reliability, predictable outcomes, and total episode cost.
Managed cross-functional launch teams across medical, regulatory, payer, sales, and analytics functions for multiple new product launches.
Oversaw annual brand plans and promotional budgets ranging from $50M to $100M, delivering campaigns that exceeded launch forecasts for Galderma's $300M aesthetic franchise.
Built physician education, KOL engagement, congress strategy, and peer-to-peer programs designed to reduce callbacks, and improve real-world treatment success.
Grew agency revenues to $40M+, directed new business pitches, and led expansion to the West Coast.
SVP, Group Account Director
Publicis Healthcare Communications Group
New York, USA
2002 - 2008
Executive leader within the largest medical education agency, supporting brands from Phase II/III through commercialization.
Led MOA development, advisory boards, congress strategy, publications, and speaker programs, driving engagement and thought leadership in dermatology, virology, women's health, and specialty medicine.
Managed large, multidisciplinary teams to deliver profitable, customized commercial solutions aligned with client objectives.
Exceeding annual budget forecasts, grew account business through strategic relationship management and innovative solutions.
Independent Consultant – Strategy & Digital Transformation at Confidential Start-UpIndependent Consultant – Strategy & Digital Transformation at Confidential Start-Up
Sr Product Manager/ Technical Consultant (Product - SAP Hybris) at Shell India Market Pvt LtdSr Product Manager/ Technical Consultant (Product - SAP Hybris) at Shell India Market Pvt Ltd